A new treatment for muscle loss using 3D printed scaffolds
MuscleInk: A multifunctional colloidal scaffold for the treatment of muscle loss
['FUNDING_SBIR_1'] · INPRINT BIO LLC · NIH-10920960
This study is testing a new way to help people recover from muscle loss after injuries or surgeries by using a special 3D printed support that helps deliver healing substances right where they're needed, making it easier for the body to heal and regain strength.
Quick facts
| Phase | ['FUNDING_SBIR_1'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INPRINT BIO LLC (nih funded) |
| Locations | 1 site (FARMINGTON, UNITED STATES) |
| Trial ID | NIH-10920960 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a novel treatment for volumetric muscle loss (VML), which often occurs after traumatic injuries or surgeries. The approach involves creating a specialized 3D printed scaffold made from a biocompatible material that supports muscle recovery by delivering growth factors directly to the affected area. By using a unique gelatin-based material that can be crosslinked in place, the treatment aims to enhance the integration of the scaffold with the patient's existing muscle tissue, potentially improving recovery outcomes. This innovative method seeks to overcome the limitations of current treatments, which often result in poor functional recovery.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing volumetric muscle loss due to trauma or surgical removal of muscle tissue.
Not a fit: Patients with muscle loss due to non-traumatic causes or those who do not have significant muscle tissue deficits may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve recovery and quality of life for patients suffering from muscle loss.
How similar studies have performed: Previous research has shown promise in using tissue engineering and 3D printed scaffolds for muscle recovery, indicating that this approach could be a viable treatment option.
Where this research is happening
FARMINGTON, UNITED STATES
- INPRINT BIO LLC — FARMINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MEMIC, ADNAN — INPRINT BIO LLC
- Study coordinator: MEMIC, ADNAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.